Pfizer's (NYSE:PFE) Lipitor cholesterol pill lost about 15% of its market share in the first few days after its patent protection ended on November 30. Meanwhile, the pharmaceutical manufacturer yesterday named CEO Ian Read as Chairman to replace George Lorch, who becomes Lead Independent Director.